Preeclampsia risk assessment across all trimesters using blood-based biochemical markers

February 13, 2024


Hear from our subject matter experts about the latest breakthrough biomarkers to help in the risk assessment and clinical management of preeclampsia across U.S. patient populations in the first, second and third trimesters.

Speakers:

Sydney Strickland, PhD, DABCC
Clinical Laboratory Director, Biochemical Genetics Discipline Director, Women’s Health and Genetics


Kelly Curd, MS, MEd, CGC
Medical Science Liaison, Women’s Health and Genetics

Labcorp can be your partner for preconception, pregnancy and pediatric care.